Statement Of Financial Position [Abstract]

Transgene - Filing #2813436

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
11 177 EUR
11 295 EUR
Intangible assets other than goodwill
77,000 EUR
92,000 EUR
Cash and cash equivalents
4 403 EUR
5 911 EUR
5 277 EUR
Assets
66 436 EUR
101 838 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
50 102 EUR
48 886 EUR
Equity attributable to owners of parent
37 841 EUR
67 209 EUR
Equity
50 628 EUR
32 804 EUR
808,000 EUR
450,000 EUR
70 813 EUR
50 102 EUR
37 841 EUR
19 536 EUR
2 933 EUR
31 092 EUR
1 423 EUR
67 209 EUR
67 441 EUR
48 886 EUR
50 716 EUR
41 921 EUR
1 051 EUR
17 231 EUR
13 861 EUR
1 726 EUR
39 212 EUR
Liabilities [abstract]
Liabilities
28 595 EUR
34 629 EUR
Equity and liabilities
66 436 EUR
101 838 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.